Reinterpreting Amitriptyline in Extra-esophageal Gastroesophageal Reflux Disease Through the GABAergic Inhibitory Axis.

Xiao Q, Li Z, Yuan A, Xiao J

Open source

DOI
10.5056/jnm26018
Published
2026 Jul 30
Container
Journal of neurogastroenterology and motility
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.5056/jnm26018,
  title = {Reinterpreting Amitriptyline in Extra-esophageal Gastroesophageal Reflux Disease Through the GABAergic Inhibitory Axis.},
  author = {Xiao Q and Li Z and Yuan A and Xiao J},
  year = {2026},
  journal = {Journal of neurogastroenterology and motility},
  doi = {10.5056/jnm26018},
  url = {https://doi.org/10.5056/jnm26018}
}

RIS

TY  - JOUR
TI  - Reinterpreting Amitriptyline in Extra-esophageal Gastroesophageal Reflux Disease Through the GABAergic Inhibitory Axis.
AU  - Xiao Q
AU  - Li Z
AU  - Yuan A
AU  - Xiao J
PY  - 2026
JO  - Journal of neurogastroenterology and motility
DO  - 10.5056/jnm26018
UR  - https://doi.org/10.5056/jnm26018
ER  - 

APA

Q, X., Z, L., A, Y., & J, X. (2026). Reinterpreting Amitriptyline in Extra-esophageal Gastroesophageal Reflux Disease Through the GABAergic Inhibitory Axis.. Journal of neurogastroenterology and motility. https://doi.org/10.5056/jnm26018

Source records